Use of botulinum toxin type A for the treatment of masseteric muscle hypertrophy

Journal of Otolaryngology

Volumn 35, Issue 1, 2006, Pages 40-43

  Arikan, Osman Kursat ^a,b   Tan, Funda Uysal ^a   Kendi, Tuba ^a   Koc, Can ^a  

^a KIRIKKALE UNIVERSITY   (Turkey)

^b KIRIKKALE UNIVERSITY   (Turkey)

Author keywords

Botulinum toxin A; Masseteric muscle hypertrophy; Treatment

Indexed keywords

BOTULINUM TOXIN A;

ADULT; ARTICLE; CLINICAL ARTICLE; DRUG EFFICACY; FEMALE; HUMAN; MALE; MASSETER MUSCLE; MUSCLE HYPERTROPHY; MUSCLE WEAKNESS; PARALYSIS; PATIENT SATISFACTION; PRIORITY JOURNAL;

BOTULINUM TOXIN TYPE A; FEMALE; HUMANS; HYPERTROPHY; MASSETER MUSCLE; NEUROMUSCULAR AGENTS;

EID: 33645033602     PISSN: 03816605     EISSN: None     Source Type: Journal    
DOI: 10.2310/7070.2005.4108     Document Type: Article

References (17)

1. Moore AP, Wood GD. The medical management of masseteric hypertrophy with botulinum toxin type A. Br J Oral Maxillofac Surg 1994;32:26-8.
2. Smyth AG. Botulinum toxin treatment of bilateral masseteric hypertrophy. Br J Oral Maxillofac Surg 1994;32:29-33.
3. Gurney CE. Chronic bilateral benign hypertrophy of the masseter muscles. Am J Surg 1947;73:137-9.
4. Gniadecka M, Weismann K, Herning M. Swelling of the temporal region: a case of benign masticatory muscle hypertrophy. Br J Dermatol 1997;136:242-4.
5. von Lindern JJ, Niederhagen B, Appel T, et al. Type A botulinum toxin for the treatment of hypertrophy of the masseter and temporal muscles: an alternative treatment. Plast Reconstr Surg 2001;107:327-32.
6. Set PA, Somers JM, Britton PD, Freer CE. Pictorial review: benign and malignant enlargement of the pterygo-masseteric muscle complex. Clin Radiol 1993;48:57-60.
7. Honda T, Sasaki K, Takeuchi M, Nozaki M. Endoscope-assisted intraoral approach for masseteric hypertrophy. Ann Plast Surg 1997;38:9-14.
8. Skoura C, Mourouzis C, Sarantes T, et al. Masseteric hypertrophy associated with administration of anabolic steroids and unilateral mastication: a case report. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2001;92:515-8.
9. To EWH, Ahuja AT, Ho WS, et al. A prospective study of the effect of botulinum toxin A on masseteric muscle hypertrophy with ultrasonographic and electromyographic measurement. Br J Plast Surg 2001;54:197-200.
10. Backers HL. Masseteric muscle hypertrophy and its intraoral surgical correction. J Maxillofac Surg 1977;5:28-35.
11. Niamtu J. Aesthetic uses of botulinum toxin A. J Oral Maxillofac Surg 1999;57:1228-33.
12. Scott AB. Botulinum toxin injection into extra-ocular muscles as an alternative to strabismus surgery. Ophthalmology 1980;87:1044-9.
13. Elston JS. Botulinum toxin treatment of hemifacial spasm. J Neurol Neurosurg Psychiatry 1986;49:827-9.
14. Kobayashi T, Niimi S, Kumada M, et al. Botulinum toxin treatment for spasmodic dysphonia. Acta Otolaryngol Suppl (Stockh) 1993;504:155-7.
15. Tsui JK, Eisen A, Stoessl A, et al. Double blind study of botulinum toxin in spasmodic torticollis. Lancet 1986;2:245-6.
16. Blitzer A, Sulica L. Botulinum toxin: basic science and clinical uses in otolaryngology. Laryngoscope 2001;111:218-26.
17. Hassan SM, Jennekens FG, Wieneke G, Veldman H. Elimination of superfluous neuromuscular junctions in rat calf muscles recovering from botulinum toxin-induced paralysis. Muscle Nerve 1994;17:623-31.